News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
756,790 Results
Type
Article (44070)
Company Profile (346)
Press Release (712353)
Multimedia
Podcasts (111)
Webinars (23)
Section
Business (212614)
Career Advice (2099)
Deals (36689)
Drug Delivery (141)
Drug Development (83428)
Employer Resources (178)
FDA (16898)
Job Trends (15558)
News (358381)
Policy (33712)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (2706)
Academic (1)
Accelerated approval (43)
Adcomms (25)
Allergies (174)
Alliances (51945)
ALS (202)
Alzheimer's disease (1809)
Antibody-drug conjugate (ADC) (435)
Approvals (17250)
Artificial intelligence (669)
Autoimmune disease (248)
Automation (56)
Bankruptcy (366)
Best Places to Work (11988)
BIOSECURE Act (21)
Biosimilars (220)
Biotechnology (222)
Bladder cancer (184)
Brain cancer (69)
Breast cancer (711)
Cancer (5683)
Cardiovascular disease (466)
Career advice (1782)
Career pathing (42)
CAR-T (320)
CDC (55)
Celiac Disease (2)
Cell therapy (860)
Cervical cancer (44)
Clinical research (72015)
Collaboration (2101)
Company closure (4)
Compensation (1328)
Complete response letters (77)
COVID-19 (2851)
CRISPR (107)
C-suite (1089)
Cystic fibrosis (149)
Data (7451)
Decentralized trials (3)
Denatured (40)
Depression (166)
Dermatology (70)
Diabetes (568)
Diagnostics (7092)
Digital health (54)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (323)
Drug pricing (203)
Drug shortages (32)
Duchenne muscular dystrophy (272)
Earnings (93423)
Editorial (67)
Employer branding (22)
Employer resources (157)
Events (126453)
Executive appointments (1104)
FDA (20524)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (34)
Funding (1719)
Gene editing (228)
Generative AI (63)
Gene therapy (708)
GLP-1 (1075)
Government (4850)
Grass and pollen (7)
Guidances (405)
Healthcare (19617)
HIV (79)
Huntington's disease (53)
IgA nephropathy (95)
Immunology and inflammation (282)
Immuno-oncology (91)
Indications (167)
Infectious disease (3189)
Inflammatory bowel disease (213)
Inflation Reduction Act (14)
Influenza (135)
Intellectual property (285)
Interviews (325)
IPO (17092)
IRA (52)
Job creations (3909)
Job search strategy (1486)
JPM (62)
Kidney cancer (19)
Labor market (95)
Layoffs (580)
Leadership (38)
Legal (8144)
Liver cancer (102)
Longevity (31)
Lung cancer (763)
Lymphoma (417)
Machine learning (57)
Management (59)
Manufacturing (1013)
MASH (186)
Medical device (14390)
Medtech (14477)
Mergers & acquisitions (20807)
Metabolic disorders (1474)
mRNA (199)
Multiple sclerosis (182)
NASH (19)
Neurodegenerative disease (404)
Neuropsychiatric disorders (104)
Neuroscience (3289)
Neurotech (1)
NextGen: Class of 2026 (6721)
Non-profit (4671)
Now hiring (74)
Obesity (694)
Opinion (300)
Ovarian cancer (201)
Pain (244)
Pancreatic cancer (278)
Parkinson's disease (361)
Partnered (35)
Patents (574)
Patient recruitment (642)
Peanut (64)
People (62133)
Pharmaceutical (77)
Pharmacy benefit managers (32)
Phase 1 (22461)
Phase 2 (31676)
Phase 3 (23629)
Pipeline (7674)
Policy (321)
Postmarket research (2602)
Preclinical (9535)
Press Release (72)
Prostate cancer (291)
Psychedelics (53)
Radiopharmaceuticals (328)
Rare diseases (1045)
Real estate (6379)
Recruiting (74)
Regulatory (25907)
Reports (55)
Research institute (2531)
Resumes & cover letters (360)
Rett syndrome (35)
RNA editing (20)
RSV (90)
Schizophrenia (174)
Series A (288)
Series B (216)
Service/supplier (13)
Sickle cell disease (113)
Special edition (23)
Spinal muscular atrophy (167)
Sponsored (50)
Startups (3804)
State (2)
Stomach cancer (20)
Supply chain (131)
Tariffs (93)
The Weekly (69)
Vaccines (1117)
Venture capital (106)
Weight loss (452)
Women's health (115)
Worklife (20)
Date
Today (138)
Last 7 days (756)
Last 30 days (2771)
Last 365 days (31450)
2026 (9776)
2025 (31318)
2024 (36371)
2023 (41245)
2022 (52531)
2021 (57141)
2020 (55728)
2019 (48212)
2018 (36330)
2017 (33414)
2016 (33131)
2015 (39193)
2014 (32841)
2013 (27824)
2012 (30045)
2011 (30667)
2010 (28695)
Location
Africa (813)
Alabama (91)
Alaska (7)
Arizona (347)
Arkansas (15)
Asia (42462)
Australia (7087)
California (12823)
Canada (3653)
China (1353)
Colorado (547)
Connecticut (557)
Delaware (388)
Europe (93184)
Florida (1908)
Georgia (419)
Hawaii (4)
Idaho (63)
Illinois (1042)
India (92)
Indiana (602)
Iowa (24)
Japan (523)
Kansas (134)
Kentucky (50)
Louisiana (39)
Maine (75)
Maryland (1550)
Massachusetts (9280)
Michigan (378)
Minnesota (711)
Mississippi (6)
Missouri (156)
Montana (36)
Nebraska (29)
Nevada (141)
New Hampshire (88)
New Jersey (3437)
New Mexico (31)
New York (3393)
North Carolina (1675)
North Dakota (10)
Northern California (6357)
Ohio (392)
Oklahoma (24)
Oregon (43)
Pennsylvania (2586)
Puerto Rico (28)
Rhode Island (50)
South America (1199)
South Carolina (83)
South Dakota (2)
Southern California (5042)
Tennessee (203)
Texas (2039)
United States (45721)
Utah (387)
Vermont (1)
Virginia (314)
Washington D.C. (84)
Washington State (1041)
West Virginia (4)
Wisconsin (131)
Wyoming (2)
756,790 Results for "krs global biotechnology inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vir Biotechnology Announces Closing of Global Strategic Collaboration with Astellas for the Treatment of Prostate Cancer
April 17, 2026
·
6 min read
Job Trends
Could biotech layoffs push life sciences talent to go global?
Amidst rising layoffs in key biotech hubs, global demand for specialized life sciences talent is driving a more borderless, distributed model of scientific work.
April 15, 2026
·
6 min read
·
Joanna Hart
Press Releases
RadNet, Inc. to Present at the 28th Annual Barclays Global Healthcare Conference on Thursday, March 12th
March 12, 2026
·
1 min read
Press Releases
Myllia Biotechnology Launches Global Virtual Cell Challenge “Echoes of Silenced Genes”
January 22, 2026
·
1 min read
Press Releases
Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer
February 24, 2026
·
10 min read
Press Releases
LumaCyte Analytical Method Included in Newly Published ISO Global Standard for Viral Vector Quantification
April 1, 2026
·
3 min read
Press Releases
Vetter Strengthens its Global Clinical Manufacturing Network with Strategic Site Enhancements
Further advancements in Europe and the US increase capacity and process efficiency ● Construction of new clinical manufacturing facility in Des Plaines on schedule ● Established Skokie site with ongoing strong performance for biotech partners ● Infrastructure upgrades at Austrian site further streamline customers’ path to clinic
April 14, 2026
·
1 min read
Press Releases
Meiji Seika Pharma’s Nacubactam to Be Featured in 10 Presentations at ESCMID Global 2026 — Including Phase III Integral-2 Results
April 15, 2026
·
4 min read
Press Releases
Vir Biotechnology Grants Norgine Exclusive Commercial License to Chronic Hepatitis Delta Treatment Candidate in Europe, Australia & New Zealand, Including Global Cost Sharing Agreement for Ongoing ECLIPSE Clinical Development Program
December 17, 2025
·
9 min read
Press Releases
ImmunityBio Strengthens Balance Sheet with $100 Million of Financing Transactions Including $75 Million of Non-Dilutive Financing to Support Global Expansion and Advancement of Broader Immunotherapy Pipeline
March 31, 2026
·
7 min read
1 of 75,679
Next
